Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
55.27
+1.49 (2.77%)
May 1, 2026, 4:00 PM EDT - Market closed
KNSA Market Cap
KNSA has a market cap or net worth of $4.25 billion as of May 4, 2026. Its market cap has increased by 184.75% in one year.
Market Cap
4.25B
Enterprise Value
3.84B
1-Year Change
184.75%
Ranking
Category
Stock Price
$55.27
Market Cap Chart
Since May 24, 2018, KNSA's market cap has increased from $943.14M to $4.25B, an increase of 350.38%. That is a compound annual growth rate of 20.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 4.25B | 35.86% |
| Dec 31, 2025 | 3.13B | 118.93% |
| Dec 31, 2024 | 1.43B | 15.76% |
| Dec 29, 2023 | 1.23B | 18.45% |
| Dec 30, 2022 | 1.04B | 28.46% |
| Dec 31, 2021 | 810.82M | -32.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hims & Hers Health | 6.25B |
| Lantheus Holdings | 5.56B |
| Alkermes | 5.55B |
| Amneal Pharmaceuticals | 4.09B |
| Liquidia | 3.39B |
| Supernus Pharmaceuticals | 2.76B |
| Prestige Consumer Healthcare | 2.61B |
| BioCryst Pharmaceuticals | 2.34B |